Clinical and Discovery Research
Accelevir leverages cutting edge technologies and platforms to develop custom fit-for-purpose solutions. We have a track record of consulting with our partners to develop a roadmap specific for each drug development and discovery program.
Clinical Development and Trials
Accelevir has implemented LDMS by Frontier Science Foundation to support the AIDS Clinical Trials Group (ACTG) testing program.
Our expanded HIPAA compliant Laboratory Information System (LIMS) supported by CGM/LABDAQ is in implementation phase.
Our standard operating procedures are designed to scale both routine and complex sample processing methods across a variety of sample types. Through an interactive process Accelevir will assist in creating and implementing customized workflows from Research Use Only (RUO), Investigational Use Only(IUO) and ultimately Companion Diagnostic (CDx).
Companion Diagnostic Partnering
Accelevir aims to bring its core expertise in ultra rare target quantitation and quality control systems to support companion diagnostic assay qualification programs. We adopt a high-touch approach, working closely with our partners to understand biomarker integration and programmatic goals.